The Belfast City Hospital in Belfast, Northern Ireland, is a 900-bed modern university teaching hospital providing local acute services and key regional specialities. Its distinctive orange tower block dominates the Belfast skyline being the third tallest storeyed building in Ireland.

There are 900 beds in Belfast City Hospital Haematology Department.

During the past decade, Belfast City Hospital Haematology Department conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Belfast City Hospital Haematology Department" are "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Belfast City Hospital Haematology Department" in a lesser frequency.

Most popular intervention types in "Belfast City Hospital Haematology Department" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (1 trials), "Lenalidomide and low-dose dexamethasone" (1 trials), "Lenalidomide plus low-dose dexamethasone given for 18 four-week cycles" (1 trials), "Melphalan, Prednisone and Thalidomide" (1 trials) and "Pomalidomide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Belfast City Hospital Haematology Department" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Belfast City Hospital Haematology Department". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Belfast City Hospital Haematology Department, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Belfast City Hospital Haematology Department, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".